NYSE American - Nasdaq Real Time Price • USD
Scorpius Holdings, Inc. (SCPX)
As of 2:06 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.63 | -0.46 |
| Low Estimate | 0 | 0 | -0.63 | -0.46 |
| High Estimate | 0 | 0 | -0.63 | -0.46 |
| Year Ago EPS | -0.47 | -0.53 | -1.74 | -0.63 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 20.6M | 35.1M |
| Low Estimate | -- | -- | 20.6M | 35.1M |
| High Estimate | -- | -- | 20.6M | 35.1M |
| Year Ago Sales | -- | -- | 7M | 20.6M |
| Sales Growth (year/est) | -- | -- | 194.50% | 70.40% |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.43 | -0.45 | -0.35 | -0.22 |
| EPS Actual | -0.47 | -0.53 | -0.5 | -0.21 |
| Difference | -0.04 | -0.08 | -0.15 | 0.01 |
| Surprise % | -9.30% | -17.80% | -42.90% | 4.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.63 | -0.46 |
| 7 Days Ago | 0 | 0 | -0.63 | -0.46 |
| 30 Days Ago | 0 | 0 | -0.63 | -0.46 |
| 60 Days Ago | 0 | 0 | -0.63 | -0.46 |
| 90 Days Ago | 0 | 0 | -0.63 | -0.46 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SCPX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 8.40% |
| Next Qtr. | -- | -- | -- | 11.90% |
| Current Year | 63.80% | -- | -- | 5.60% |
| Next Year | 27.00% | -- | -- | 13.00% |
| Next 5 Years (per annum) | -- | -- | -- | 11.05% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | Brookline Capital: Buy to Hold | 5/1/2023 |
| Downgrade | Maxim Group: Buy to Hold | 4/3/2023 |
| Initiated | Cantor Fitzgerald: Overweight | 3/3/2021 |
Related Tickers
VAXX Vaxxinity, Inc.
0.0550
-8.33%
LYRA Lyra Therapeutics, Inc.
0.3638
-2.21%
AZTR Azitra, Inc.
0.1761
+0.11%
GLYC GlycoMimetics, Inc.
0.2782
+0.80%
TOVX Theriva Biologics, Inc.
0.3690
-1.34%
ALLR Allarity Therapeutics, Inc.
0.6826
-13.56%
FWBI First Wave BioPharma, Inc.
2.7600
-7.38%
RNAZ TransCode Therapeutics, Inc.
0.8515
+16.63%
TNXP Tonix Pharmaceuticals Holding Corp.
0.1826
+1.44%
PXMD PaxMedica, Inc.
0.2250
+8.70%